Evidence map›Paper›PMID 38319286›Full record

ArticleMolecular cancer research : MCR2024

Oncogenic GNAS Uses PKA-Dependent and Independent Mechanisms to Induce Cell Proliferation in Human Pancreatic Ductal and Acinar Organoids.

Ridhdhi Desai, Ling Huang, Raul S Gonzalez, Senthil K Muthuswamy

Open access · greenAbstract read
In one paragraph

Article in Molecular cancer research : MCR, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Contract to kill: GNAS mutation.Molecular cancer · 2025
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ridhdhi DesaiDepartment of Medicine, Beth Israel Deaconess Medical Center, Cancer Research Institute, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-6197-4122
Ling HuangDepartment of Medicine, Beth Israel Deaconess Medical Center, Cancer Research Institute, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-8855-788X
Raul S GonzalezDepartment of Medicine, Beth Israel Deaconess Medical Center, Cancer Research Institute, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-5526-4220
Senthil K MuthuswamyLaboratory of Cancer Biology and Genetics, NCI, NIH, Bethesda, Maryland.ORCID 0000-0001-6564-9634
Beth Israel Deaconess Medical Center · USNational Cancer Institute · US

Funding

Tumor organoids and cell polarity: models and mechanisms for cancer researchZIABC012132 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MUTHUSWAMY, SENTHIL · 2023 to 2025
$7.5M
To investigate the molecular and cellular mechanisms through which KRAS and BRAF oncogenes regulate cell polarity during epithelial morphogenesisF32GM115201 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI DESAI, RIDHDHI R · 2015 to 2017
$173k
Intramural NIH HHS Z99 CA999999NIGMS NIH HHS F32 GM115201
6 · The paper itself

Abstract

implicationsThe study identifies an opportunity to discover a PKA-independent pathway downstream of oncogene GNAS for managing IPMN lesions and their progression to PDAC.

Indexed as

Cell ProliferationChromograninsCyclic AMP-Dependent Protein KinasesGTP-Binding Protein alpha Subunits, GsOrganoidsPancreatic NeoplasmsAcinar CellsCarcinoma, Pancreatic DuctalHumansPancreatic DuctsChromograninsCyclic AMP-Dependent Protein KinasesGNAS protein, humanGTP-Binding Protein alpha Subunits, Gs

Identifiers

PMID38319286
PMCPMC10906748
OpenAlexW4391563627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.